Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
140 Cards in this Set
- Front
- Back
opioid high efficacy agonists
|
morphine
merperidine heroin fentanyl |
|
opioid low-med efficacy agonists
|
codeine
oxycodone propoxyphene |
|
opioid mixed agonist/antagonists
|
pentazocine
|
|
opioid antagonist
|
naloxene
|
|
non-analgesic opioids
|
dextromethorpan
loperimide |
|
what is a narcotic?
|
sleep inducing
|
|
what is an opiate?
|
compound with pharmacology similar to morphine (opiates, synthetic drugs, ligands)
|
|
what is an analgesic?
|
pain reliever
|
|
opiod affects aside from analgesia?
|
N/V, cough suppression, urinary retention, antidiarrheal/constip, resp. depression, miosis, CNS dep, altered endocrine, altered immune, biliary spasm, histamine release, mood effects, dependence
|
|
endogenous opioid characteristics
|
- mimic endogenous peptides in brain and periphery
- multiple functions - bind to opioid receptors - three families (POMC/beta-endorphin, enkephalins, dynoprhins) |
|
three families of endogenous opioids?
|
- POMC/beta-endorphin
- enkephalins - dynorphins |
|
-gene product of POMC?
-hormones synthesized from POMC? -where is it? - receptors? |
gene product = POMC
hormones = ACTH, b-lipotropin, MSH where = hormonal(pituitary), brain receptors = mu, kappa, delta |
|
-gene product of pro-enk?
-charac? -where is it? - receptors? |
gene product = pro-enk
charac = multiple opioid active peptides, small size (5-8aa) where = brain rec = delta, mu agonist |
|
-gene product of pro-dynoprhin?
-charac? -where is it? - receptors? |
gene product = pro-dynorphin
charac = multiple opiod peptides, small-med where = brain receps = kappa, delta, mu |
|
opioid receptors
|
mu
kappa delta |
|
non opioid receptors
|
sigma
DM |
|
effects of Mu receptor
|
- major receptor
- classic effects analgesia resp. depression euphoria dependence |
|
effects of kappa receptor
|
few drugs are kappa agonist
analgesia (spinal) sedation endocrine dysphoria psychomimetic |
|
effects of delta receptor
|
unclear clinical significance
- analgesia |
|
effects of sigma receptor
|
agitation
hallucination dysphoria |
|
what are the major cellular effects of opioids?
|
inhibitory
|
|
activation of opioid receptor will?
|
inhibit cAMP production - decreased phosphorylation
inhibit Ca channels- on prejunctional neurons (inhibit NT release) activate K channels - increase K conduction --> hyperpolarize postjunctional cells |
|
response of neuron to opioid activation?
|
decreased spontaneous firing
decreased evoked firing inhibited transmitter (NT) release |
|
example of cellular effects of opioids?
|
inhibition of pain message from periphery (image in notes) - via inhibitory, enkephalin interneuron
|
|
sites of opioid analgesia?
|
spinal = dorsal horn
supraspinal = central gray thalamus limbic system sensory cortex |
|
general effects of opioid analgesia?
|
increased pain threshold
increased pain tolerance selective for analgesia (little effect on other senses) |
|
types of pain treated with opioids
|
good =
slow, dull pain (C fiber) not fast, sharp (A/delta) nociceptive pain not neuropathic pain |
|
primary afferent pain fibers
Aalpha/Abeta |
Aalpha/Abeta
myelinated large propioception, light touch |
|
primary afferent pain fibers
Adelta fibers |
lightly myelinated
medium diameter nociception (thermal, mechanical, chemical) |
|
primary afferent pain fibers
C fibers |
unmyelinated
small diameter innocuous temperature, itch nociception |
|
what phase of pain are opioids better for?
|
2nd pain
|
|
where do opioids produce analgesic effects?
|
sites of synaptic transmission along pain pathway
|
|
are opioid receptors stereoselective? if so, how?
|
yes.
active isomers = d no - opioid effects (no analgesia, no resp dep or euphoria) yes - antitussive effects active isomers = l (natural) yes - opiod effects yes - antitussive effects |
|
what are the anti-diarrheal (constipating) effects of opioids?
what are the results? where? tolerance? |
organ effects =
dec propulsive movements (inc tone,peristalsis) dec secretions result= delayed gastric emptying inc transit time inc water abs. where? peripheral/CNS tol? little tol. |
|
what is the significance of the opioid caused delay in gastric emptying?
|
transit of the drug is shut down...less drug appears in blood
|
|
main therapeutic effects of opioids?
|
analgesia
antitussive antidiarrheal - constipation mood enhancement - abuse |
|
common adverse effects of opioids?
|
constipation
N/V sedation miosis tolerance itch |
|
less common adverse effects of opioids?
|
resp. depression
dysphoria uriniary retention postural hypotension truncal rigidity dependence |
|
what is the most dangerous adverse effect?
|
resp depression
- ***dec response of medullary resp. center to pCO2 - dec in rate, depth, irregular rhythm, pCO2 incs. - monitor = parenteral ex) COPD (not in normal use patients) - additive to depressive/sedative hypnotics - cause of death = opiod overdose |
|
triad of opioid overdose
|
coma
resp dep pinpoint pupils |
|
sedation caused by opioids
|
additive with other drugs
interferes with sleep patterns, REM |
|
N/V caused by opioids
|
20-40% patients
CTZ and vestibular components |
|
miosis caused by opioids
|
no tolerance
|
|
urinary retention and opioids
|
inc. urgency and diff. voiding
autonomic effects inc. ADH |
|
cardiovascular effects of opioids
|
no direct heart effects
histamine release beneficial in pulm. edema postural hypo. avoid with shock |
|
opioid induced biliary tract spasm
|
but..used to tx biliary colic
|
|
truncal rigidity and opioids
|
prob = fentanyls
more resp. depression |
|
neuroendocrine effects of opioids
|
inc - GH, ADH, prolactin
dec - FSH, LH, CRF, ACTH |
|
inc. intracranial pressure and opioids
|
secondary to inc. pCO2
|
|
labor and delivery and opioids
|
dec uterine tone
neonatal intoxication |
|
altered immune function?
|
secondary to altered stress hormones
|
|
opioid cautions/CIs
|
head injuries (inc. intrac. press)
pregnancy imp. pulm fxn (COPD) imp. renal fxn (exc) addisions, hypothyr. (bc of dec. CRH, ACTH) substance abuse hx MAOIs - dangerous drug intxns. |
|
discuss the significance of opioids and first pass elim.
|
oral dose = must be higher than parenteral (though same effect results)
|
|
routes of admin of opioids?
|
oral
buccal sublingual transdermal nasal suppository parenteral (IM, SC, IV) intrathecal (labor) |
|
duration of opioids?
|
most = 3-4 hrs
meperidine - less methadone - more |
|
which opioids have increased duration with slow release oral preps?
|
morphine
oxycodone oxymorphone |
|
what is another preparation method to increase opioid action?
|
transdermal prep.
|
|
what enhances opioid abuse potential?
|
fast CNS penetration!
heroin vs. morphine |
|
how are opioids metabolized and excreted?
|
- liver oxidation/glucuronidation
RAPID! - renal excretion - morphine- 6- glucuronide active at receptor (but doesnt penetrate BBB) |
|
does morphine -6- glucuronide opioid cross the BBB?
|
no!
|
|
do opioids exhibit tolerance?
|
yes! likely with repeated use
|
|
when does a pt. experience tolerance?
|
not clinically significant at first...become extreme when doses are pushed and administration is repeated
- a larger dose will be needed to result in the same effect |
|
discuss opioid tolerance and safety.
|
tolerance does not affect safety
- TI is unchanged |
|
which effects exhibit tolerance to opioid actions?
|
all but constipation and mioisis
|
|
is there cross tolerance?
|
tolerance can be conferred from one agonist to another
- when substituting a new drug, start with .5 of the equi-analgesic dose and build back up as needed for successful analgesia |
|
how can the same effect of an opioid maintain itself over time?
|
dose must be increased due to tolerance development
|
|
what are the two kinds of opioid dependence? what kind of use causes this?
|
physical - chronic
psychological - addictive |
|
describe physical dependence.
|
abstinence syndrome - drug removal
- some likely to occur, readily managed - intensity and time course = function of dose, kinetcis of drug - cross dependence is seen with other drugs |
|
describe psychological dependence.
|
- addiction
- altered behavior (drug seeking) - rare occurrence with normal clinical use |
|
do physical and psychological dependence always occur together?
|
no! they are different
|
|
what is used to measure the intensity of opioid withdrawl?
|
sum of withdrawl symptoms!
resp rate bp temp sleep caloric intake weight sum = intensity of abstinence syndrome |
|
what drug characteristic is used to measure intensity and duration of withdrawl symptoms?
|
kinetics!
ex) morphine (fast onset) vs. methodone (slow onset) |
|
significance of the oral:parenteral ratio?
|
decreased ratio = decreased first pass effect.
|
|
what are the classes of opioid drugs?
|
high efficacy analgesics
low-medium efficacy oral analgesics mixed ag-antagonists (misc) antags. non-analgesic opioids |
|
what are the first line high efficacy opioid analgesics?
|
morphine
methadone fentanyl |
|
what are the second line high efficacy opioid analgesics?
|
merperidine
heroin |
|
what is the prototype high efficacy opioid analgesic? how is it administered?
|
morphine - slow release, oral
|
|
what drug is more potent and soluble than morphine?
|
hydromorphone
|
|
which drug is short acting and often used in anesthesia?
|
fentanyl
|
|
what routes of admin. apply to fentanyl?
|
parenteral
transdermal oral lozenge buccal tablet |
|
when is methadone used? why?
|
heroin tx
- good oral:parenteral ratio - long acting |
|
what is unique about oxymorphone?
|
new extended release preps.
|
|
which high efficacy opioid analgesic drug is a pro-drug?
|
heroin = converted to morphine
- not legal |
|
which drug is often compared to morphine?
|
meperidine
|
|
which effects of meperidine are considered similar to morphine?
|
analgesia
resp. dep dependence likelihood |
|
are the following effects of meperidine greater or lesser than morphine?
- N/V - dizziness - toxicity |
greater than morphine!
|
|
are the following effects of merperidine greater or lesser than morphine?
- constip/urin. ret. - delay of labor - biliary spasm - cough supp - miosis - duration |
less than morphine!
|
|
what is normeperidine?
|
toxic metabolite of meperidine
|
|
what does normeperdine cause?
|
CNS stim and convulsions
|
|
under what conditions does normeperdine accumulate?
|
- chronic dosing
- esp : oral dosing impaired kidney fxn. |
|
when is normeperidine used?
|
short term!!! less than 48 hrs.
|
|
what does normeperidine interact with? is it fatal?
|
MAOIs...YES!
|
|
what are the first line low-med efficacy opioid analgesics? what is there route of admin?
|
codeine
oxycodone proproxyphene oral! |
|
what are the first line low-med efficacy drugs?
|
codeine
oxycodone propoxyphene |
|
what is the most efficacious low-med eff. opioid? how is it admin?
|
oxycodone
- often classified as high eff. - slow release prep. (often abused) |
|
which drug is low efficacy, req. metabolic activation (deficient in 10% of pts), and a good antitussive at lower doses than analgesia?
|
codeine
|
|
describe propoxyphene.
|
- low efficacy
- high toxicity |
|
which low-med opioid is very toxic and often avoided?
|
propoxyphene
|
|
how are low-med efficacy opioids analgs. admin?
|
oral!
|
|
what is often given in combo with low-med effic. opioid analgs?
|
ASA
APAP NSAIDS |
|
describe the receptor activity of pentazocine. what category?
|
kappa = agonist
mu = antagonist, partial agonist (mixed ag/antag) |
|
what are the benefits of mixed ag/antags?
|
lower dependence
overdoes toxicity is uncommon! |
|
what are the drawbacks of mixed ag/antags?
|
dose rel. psychomimetic effects
other adv.effects ceiling on analgesia ppt withdrawl in pts on full agonists |
|
describe opioid antagonists.
|
competitive at all opioid receptors.
not competitive at non-opioid rec (DM) |
|
what is naloxene? how is it administered? describe its effect pattern?
|
opioid antagonist! parenteral only. rapid action, slow duration.
|
|
what are the categories of non-analgesic opioids?
|
antitussives
antidiarrheals |
|
what is dextromethorpan? where does it act?
|
antitussive
acts at = DM R. doesnt act at = opioid R. |
|
which non-analgesic opioid has little BBB penetration?
|
loperamide (active in immodium)
|
|
what are the main assessments in pain tx?
|
1) assess type of pain
2) assess intensity of pain |
|
what are the diff. types of pain?
|
acute vs. chronic
nociceptive vs. neuropathic |
|
is pain subjective or objective?
|
subjective..it must be evaluated. continual re-eval assesses reponse to drug and disease progress
|
|
are drug efficacies important is pain assessment?
|
yes. diff drug efficacies det. pain intensities.
|
|
what is the three step approach to pain tx?
|
mild pain
moderate pain severe pain |
|
how to tx mild? mod? severe?
|
mild = nonopioid analgs.(ASA, NSAIDS, APAP)
mod = oral opioids (mild tx + oral op of low-med effic) sev = high effic opioids par/oral, alone or with adjuncts |
|
what term describes the fact that high efficacy opioids differ in potency, but the same relief is attainable via dose adjustment?
|
equi- analgesia
|
|
what are two other principles of pain tx?
|
equi-analgesia
use approp. route! |
|
which route of admin is preferred in pain tx?
|
oral. though, dose must be inc. to attain effect of parenteral potency
|
|
is there a wide variety of admin. routes available for opioids?
|
yes. even for some specialty situations.
- parenteral NSAID = ketorlac. |
|
describe the relationship between drug duration and pain duration.
|
match them!
|
|
how long is opioid duration generally?
|
3-4 hrs
|
|
name some uses for opioid pain relief
|
brief surgical procedures
fractures post-op pain recurrent severe pain (sickle cell) terminal cancer |
|
which opioid has longer duration?
|
methadone
|
|
describe the duration of fentanyls.
|
short action.
|
|
why are patch and slow release. oral preps of fentanyl available?
|
they are longer acting formulations of the drug
|
|
how is breakthrough pain treated?
|
combine long and short acting opioids.
|
|
what causes the cycle of pain?
|
prn administration
|
|
what type of dosing is appropriate for opioids?
|
regular dosing schedule (not prn)
|
|
what kind of pumps are an option?
|
PCA pumps (pt. controlled analgesia)
|
|
does oral administration result in higher or lower concentrations than parenteral? does it peak earlier or later?
|
oral peaks lower and later than parenteral.
|
|
is easier to maintain pain free or to remove existing pain?
|
pain free.
|
|
describe the 4 characteristics of opioid tolerance.
|
- may not see it with normal use, but it can occur when pushing dose.
- cross tolerance occurs when switching meds - saftety margin doesnt change with tolerance - no tolerance to constipation (it will occur) |
|
what side effect will occur with tolerance?
|
constipation
|
|
should opioids be witheld due to a fear of addiction?
|
no.
- iatrogenic addiction is rare - opioid dep. pts. require pain relief - addiction is irrelevant with terminally ill pts. |
|
what types of pain are difficult to tx? why?
|
diabetic neuropathy
postherpetic neuralgia fibromyalgia phantom limb why? bc not inflamm. or tissue damage - path is in sensory nerve or CNS processing |
|
what drugs are successful with diff. pain tx?
|
antidepressants
anticonvulsants |
|
what is ziconitide?
|
n-type Ca channel blocker used to tx neuropathic pain
|
|
how is ziconitide administered?
|
intrathecal ($$$)
|
|
what kind of side effects does ziconitide have?
|
severe
- CNS dep. - psychiatric |
|
describe antidepressants and neuropathic pain tx.
|
most common - tricyclics
= SSRIs are less efficacious = newer drugs are better - SNRIS - duloxetine (FDA approved for diabetic neuropathy) |
|
describe anticonvulsants and neuropathic pain tx.
|
- widely used off label
- phenytoin, sodium valproate, clonazepam, lamotrigine, topiramate = FDA App - carbamezipine = diabetic - gabapentin = postherpetic - pregabalin = both |